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Abstract
The rapid development of high throughput biotechnologies has led to an onslaught of data
describing genetic perturbations and changes in mRNA and protein levels in the cell. Because
each assay provides a one-dimensional snapshot of active signaling pathways, it has become
desirable to perform multiple assays (e.g. mRNA expression and phospho-proteomics) to measure
a single condition. However, as experiments expand to accommodate various cellular conditions,
proper analysis and interpretation of these data have become more challenging. Here we introduce
a novel approach called SAMNet, for Simultaneous Analysis of Multiple Networks, that is able to
interpret diverse assays over multiple perturbations. The algorithm uses a constrained optimization
approach to integrate mRNA expression data with upstream genes, selecting edges in the protein-
protein interaction network that best explain the changes across all perturbations. The result is a
putative set of protein interactions that succinctly summarizes the results from all experiments,
highlighting the network elements unique to each perturbation. We evaluated SAMNet in both
yeast and human datasets. The yeast dataset measured the cellular response to seven different
transition metals, and the human dataset measured cellular changes in four different lung cancer
models of Epithelial-Mesenchymal Transition (EMT), a crucial process in tumor metastasis.
SAMNet was able to identify canonical yeast metal –processing genes unique to each commodity
in the yeast dataset, as well as human genes such as β-catenin and TCF7L2/TCF4 that are required
for EMT signaling but escaped detection in the mRNA and phospho-proteomic data. Moreover,
SAMNet also highlighted drugs likely to modulate EMT, identifying a series of less canonical
genes known to be affected by the BCR-ABL inhibitor imatinib (Gleevec), suggesting a possible
influence of this drug on EMT.
Introduction
Cells respond to external stimuli at many levels, including changes in gene and subsequently
protein expression levels, post-translational changes to proteins, changes in subcellular
localization and changes in levels of small molecules. While some of these changes can be
measured via mRNA expression assays1, alternative technologies are needed to capture the
full response. For example, genetic screens can identify genetic mutations that change a
cellular response to a particular perturbation2, phosphoproteomics assays can identify
changes in protein activity3, transcription factor binding assays4 can identify changes in
binding activity and epigenetic screens can detect changes in chromatin structure 5.
However, each experiment only detects a fraction of the total cell state, making
interpretation of the experiments challenging.
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The cataloging of protein-protein interactions across species and conditions into databases
such as STRING6 has fueled the development of computational algorithms that search for
relationships between various genes. These algorithms use the published interactome as a
blueprint for putative signaling pathways then identify which signaling pathways best
explain the changes measured with specific high-throughput assays. Given a set of genetic
hits and differentially expressed mRNA, various approaches have been used to identify
signaling pathways active in these experiments, such as dynamic programming-based
methods7, probabilistic models of the underlying pathways8, and network-flow based
optimization approaches9. Other network approaches, such as Steiner tree-based algorithms,
have been shown to identify proteins that best explain the presence of genetic hits in the
interactome (without expression data)10. Steiner trees have also been used to explain
expression changes downstream of phosphorylation activity11,12.
In this work we introduce SAMNet, for Simultaneous Analysis of Multiple Networks, an
algorithm that uses a network flow model to integrate two distinct high-throughput
experiments across multiple conditions. Our approach is motivated by the fact that cellular
responses to many distinct biological perturbations show significant overlap, a fact that has
been recognized since pioneering work by Gasch et al.13 As a result, independent analysis of
data from different perturbations will be biased toward revealing the common pathways at
the expense of the specific responses. By adopting a multi-commodity flow-based approach,
SAMNet identifies interactions from the protein-protein interaction network that are unique
to each condition.
Network flow algorithms are a family of algorithms that select a combination of edges in a
network that provide the best path from a designated source to a designated sink. The
earliest mention of network flow in the context of the protein interaction network is the
FunctionalFlow algorithm used to ascribe function to unknown proteins by quantifying the
flow through the weighted interactome from proteins of known function14. ResponseNet, a
single-commodity flow algorithm used phenotypic and mRNA expression data to study the
effects of alpha-synuclein toxicity9. More recently, a multi-commodity variant was used to
characterize the results of RNA interference experiments in yeast15,16. Information flow
models make up a similar class of algorithms that model the interactome as an electrical
circuit, where each edge acts a resistor and carries the current from an artificial source to
each gene in the network to determine its importance. Information flow algorithms have also
been used to integrate genetic and expression data within the protein interaction
network17–20 as well as random walk approaches21.
SAMNet uses a constrained optimization formulation based on the multiple commodity flow
problem to model multiple experiments simultaneously as “commodities” that must transit
from a common source to a common sink through a shared protein interaction network. Each
edge in the interaction network has a particular capacity, and therefore must be ‘shared’ by
all commodities. This constraint forces the algorithm to select interactions that are unique to
each cellular perturbation, thus avoiding the selection of common stress pathways, a
common pitfall of other optimization approaches. We test SAMNet on two distinct datasets.
We model the effect of seven different transition metals on the budding yeast
Saccharomyces cerevisiae22 through integration of genetic mutant and mRNA expression
data. Having shown that the algorithm can identify meaningful biological pathways across
the 14 datasets (seven conditions, two assays each), we also used the algorithm in a model of
Epithelial-Mesenchymal Transition (EMT) in human lung cancer cell lines23.
Our results indicate that SAMNet is a powerful tool for modeling diverse sources of high
throughput data across multiple experiments. As the cost of performing these experiments
decreases, the relative cost of analysis will only rise. By selecting relevant proteins and
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interactions that are unique to cellular perturbations, SAMNet provides a crucial step in the
preliminary processing of these data and can be used to generate further hypotheses from the
data.
Materials and Methods
Network-based integration of ‘omics’ data
We modeled our approach on a previous algorithm, ResponseNet,9 in which genetic hits
were connected to an artificial node representing the “source” of “flow” and the
differentially expressed genes were connected to an artificial node representing the “sink”.
The algorithm then selected the best edges and nodes through which the “flow” could run
from the source to the sink based on a cost for each edge, ultimately representing the best
combination of protein-protein and protein DNA interactions that explained the genetic and
transcriptional data.
Similarly, we represent the proteins, mRNA and their interactions as a graph G = (V, E)
where the vertex set V represents proteins and mRNA while the edge set E represents
putative physical interactions between them. Figure 1 depicts G. The vertex set V is
comprised of both proteins (squares and circles in Figure 1) and mRNA (diamonds in Figure
1). Edges among proteins (solid lines in Figure 1) are derived from prior knowledge about
protein-protein interactions and edges between proteins and mRNA are derived from
inferred protein-DNA interaction networks (dashed lines in Figure 1). A gene is included as
an mRNA node if the gene is putatively transcribed by a protein present in the protein-
interaction network and a gene is included as a protein node if the translated gene is known
to interact with another protein. As such, it is possible to have a gene represented in both
mRNA and protein form, as it can exist in both states in the cell.
Network optimization formulation
In the original graph G, there are two subsets of nodes that represent the biological
experiment in question, one representing the differentially expressed mRNA for each
condition k, labeled exprk (diamonds in Figure 1), and one representing the upstream
modifiers, either genetic hits or phosphorylated proteins in each condition k, labeled hitsk
(rectangles in Figure 1). Proteins/mRNA identified in the original experiments that have no
known interactions are omitted from the network.
While ResponseNet had a similar formulation, SAMNet differs from ResponseNet by
representing each cellular condition as a commodity, which is an abstraction derived from
the field of operations research to represent a collection of goods that must travel from one
point (in this case, the source S) to another (the sink T). Each condition, for instance a cell
state with a specific perturbation, is represented by its own commodity. This enhancement
requires modifying the ResponseNet optimization from a basic network flow algorithm to a
multi-commodity network flow formulation to allow for shared use of the same underlying
network G without allowing flow to travel from the hits in one condition to the differentially
expressed genes from another condition (hiti to exprj).
The non-zero edge weights wijk>0 in G represent confidence in the interaction between the
two proteins and are and equivalent across all commodities. We also add a capacity
constraint capij for each edge that is set to 1 in the original graph G.
The graph G is then augmented as follows to incorporate the specific perturbation data:
1. G = (V, E, C), where C represents the set of commodities, or conditions, to be
evaluated. The sets of vertices and edges are the same for each commodity.
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2. V’ = V ∪ {S, T}, where S and T are auxiliary nodes representing the source and
sink of the network.
3. E’ = E ∪ {(S, i, k)∀i ∈ hitsk, ∀ k ∈ C} ∪ {(j, T, k)∀j ∈ exprk, k ∈ C}. This update
creates condition-specific edges between the source and genetic hits for a particular
condition k, and also between mRNA differentially expressed in condition k and
the sink.
4. Weights from the S to genetic hits wSik represent growth deficiency in the yeast
data as defined by Jin et al.22 and absolute log fold change in phosphorylation
activity as described by Thomson et al23. We define the capacities from the source
to genetic/phospho-proteomic hits such that they sum to 1 for each commodity:
.
5. Weights wiTk from the mRNA nodes to T represent the absolute log-fold change of
the mRNA under perturbation k in the original data22,23. We define the capacities
from the expression values to the sink as the weights normalized to 1 for each
commodity: .
We define the flow variable fijk to represent the flow from node i to node j for commodity k.
We then use CPLEX version 12.4.0 (freely available for academic purposes from the IBM
website) to solve the following linear program:
(1)
Subject to:
(2)
(3)
(4)
(5)
This linear program is comprised of an objective function (Equation 1) and a series of
constraints (Equations 2-5) that together identify a putative set of edges that best explain the
connection between upstream signaling changes and changes in mRNA expression. The
objective function finds a balance between large networks that explain many connections
but use low-confidence edges, and small networks that explain very little of the data but use
high-confidence edges. This balance is achieved by maximizing the total flow in the
network while minimizing the total cost of the weight of each edge multiplied by the flow
passing through it (fijk ). The parameter γ is a tuning parameter that effectively controls the
size of the network by altering the balance between these two goals. Equations 2 to 5 are
constraints that are required for the following purposes: Equation 2 maintains the
conservation of flow, forcing the flow entering a particular node to also leave that node,
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unless that node is the source S or the sink T. Equation 3, called demand satisfaction,
ensures that all flow is accounted for – everything that leaves the source S must reach the
sink T. Equation 4, the capacity constraint, forces all commodities to share the capacities of
the edges. Equation 5 ensures non-negative flow. The primary difference between this
approach and the single-commodity flow in the ResponseNet algorithm9 is Equation 4,
which requires that the combined flow of all commodities passing through an edge be
limited to a single capacity value. This requirement prevents components of the response
that are common to many conditions from dominating the networks.
Python scripts that run SAMNet, as well as the ensuing analysis including GO and KEGG
enrichment determination are publicly available at http://www.github.com/sgosline/
SAMNet.
Yeast transition metal dataset analysis
To evaluate the efficacy of the algorithm we used a published yeast dataset that measured
both the growth phenotype and mRNA expression levels upon treatment with different
metals22. In this study, the yeast deletion library was screened with seven different transition
metals, each at their respective EC50 concentration (50% total effective concentration).
Genetic hits were defined as mutations that cause cells treated with the transition metal to
grow at least 50% slower than wild type treated with the same concentration of metal.
mRNA expression data was also retrieved from the same set of experiments, and
differentially expressed genes (p<0.01 as defined by the original experiment) were included
in our final set. The total number of genetic hits and differentially expressed genes are in
Table 1.
The genetic hits and differentially expressed genes have very little overlap (at most eight
genes for any of the seven commodities), as expected from previous analysis22.
Furthermore, clustering either the genetic or the expression profiles suggests very different
relationships among the transition metals, as shown in Figure S1A and S1B. Figure S1A
illustrates the clustering of growth inhibition values of genetic hits across all metals. Figure
S1B depicts the clustering of mRNA expression changes upon treatment with the same
metals. The disagreement between dendrograms illustrates the differences in the two types
of data.
To construct graph G described above with the yeast data, we represented edges between
proteins with predicted protein-protein interactions derived from the STRING database6
using interactions with supporting experimental evidence and a confidence score >0.6.
Differentially expressed mRNA were connected to the network using predicted protein-
DNA interactions derived from published ChIP data binding sites of the entire set of yeast
transcription factors and then filtered for known transcription factor motifs as described by
MacIsaac et al.24 Only genetic hits that had predicted interactions (either with mRNA or
with other proteins) were included in the network. mRNA nodes were distinct from protein
nodes to avoid conflating the two types of molecules, as protein interactions cannot occur
between untranslated mRNA.
On the yeast interactome (6190 nodes and 114973 edges in G’), the algorithm took ~ 5
minutes to complete on a 64-bit server with four dual-core processors and 16 GB of RAM.
We defined the predicted network as F = {fijk > 0}. We selected a γ parameter of 15 to
maximize the robustness of the algorithm as described below. The resulting network had
1706 nodes and 2662 edges. The network can be found in Cytoscape format in the data/
yeast_metal/metalOutput subdirectory of the online source code repository.
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Human EMT dataset analysis
To illustrate the ability of our algorithm to scale to a more complex organism and interpret
other types of data, we evaluated previously published data that compared epithelial non-
small cell lung cancer (NSCLC) cells to fixed mesenchymal cells as well as to cells with
epithelial mesenchymal transition (EMT) artificially induced23. To better determine the role
of distinct signaling pathways in EMT, this study stimulated the transition via three distinct
mechanisms (which are known to work together in the cell) to identify the specific influence
each pathway may have on the cell. We believed that SAMNet could better identify specific
differences between the three modes of EMT induction by comparing them in a network
context.
From this publication we collected mRNA expression levels and phospho-protein levels in
H358 epithelial cells with EMT induced via three different mechanisms -- over-expression
of Zeb1, over-expression of Snail, or stimulation with TGFβ. mRNA fold changes values
were collected from the original manuscript and only those mRNA that exhibited at least an
absolute fold change difference of two and p<0.05 were included in the set of differentially
expressed mRNA. The authors also collected mRNA expression changes between two
epigenetically fixed mesenchymal cells –Calu6 and H1703—and compared them with the
two epithelial cells (H358 and H292). To average the effects of two cell lines together,
mRNA were considered to be differentially expressed if the absolute change between the
average mRNA in both fixed cell lines and the average mRNA in the epithelial was greater
than 1.5. Phospho-peptides were identified by tandem mass-spectrometry with proteins
selected as differentially phosphorylated if peptides containing a phosphoserine,
phosphothreonine or phosphotyronine were identified at ≥95% confidence, fold changes
between those peptides were in the upper or lower distribution quartiles (>75% or <25%)
and the changes in expression represented p<0.05 according to a t-test. The number of
differentially phosphorylated proteins and differentially expressed mRNA are described in
Table 2.
We connected phosphorylated proteins to putative transcription factors using the PSIQUIC
interactome25, selecting only those edges with a confidence score greater than 0.5. We then
connected the interactome to differentially expressed mRNA using putative protein-DNA
interactions derived as follows. We downloaded DNase I hypersensitivity data from the
ENCODE consortium performed on the A549 cells, another lung cancer cell line5. We then
added an edge between a transcription factor t and an mRNA m if the TRANSFAC MATCH
algorithm26 identified a binding site within a DNase I hypersensitive site for t within 5 kb of
the transcription start site of m and m was the closest gene to that site. We ran MATCH
using the minFP.prf file that provides thresholds for each motif that are high enough to
minimize false positive identifications of transcription factor binding sites.
With the human interactome (limited to interactions with a confidence score >0.5) and four
conditions, the results took < 1 minute to complete. We selected a γ parameter of 14 to
maximize the robustness (described below), at which point the final network had 357 nodes
and 411 edges. . The final network in cytoscape format can be found in the data/human_emt/
emtOutput subdirectory in the online source code repository.
Identifying parameters yielding robust networks
To implement SAMNet we needed to identify the optimal parameters for network flow (γ)
and construction of the transcription factor-gene network. Ideally, these parameters would
show the best performance in recovering true signaling networks. However, as no signaling
network is completely known, there are no gold standard datasets that can be used for this
Gosline et al. Page 6
Integr Biol (Camb). Author manuscript; available in PMC 2013 November 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
purpose. Instead, we assumed that the optimal parameters would identify networks robust to
noise in the input data.
To determine the optimal value of γ, we ran SAMNet after omitting fractions of the input
data and then calculated the specificity and sensitivity of the networks obtained from the
random subsamples. More specifically, we generated 300 different sets of input for each
dataset as follows. Fifty of the sets were missing a randomly chosen 10% of the genetic hits
(phospho-proteins for the Human dataset) and 50 sets were missing a randomly chosen 10%
of the differentially expressed genes. Similarly, 50 randomly chosen inputs were missing
either 30% or 50% of either the genetic hits or differentially expressed genes. We varied the
network flow parameter γ in both the yeast and human datasets, rerunning the optimization
on each of the 300 subsets of the data to identify the value at which the resulting networks
were most similar to the original network. Specifically, for each resulting network p, we
calculated the fraction of nodes in the original network found in p (specificity) and how
many nodes in p were in the original network (sensitivity). We then averaged the specificity
and sensitivity measurements across all 100 resulting networks for each fraction of data left
out (10%, 30%, 50%) to arrive at the values in Tables S1 and S3.
The results are in Figure S2 and Table S1 for Yeast. Human results are in Table S3 and
Figures S4 and S5. Careful analysis of the values in Tables S1 and S3 revealed that a γ value
of 15 for the yeast dataset and 14 for the human dataset result in the highest specificity and
sensitivity over all the commodities.
Because using DNAse I hypersensitive sites followed by motif search has only recently
become a common way of determining tissue-specific binding sites27, we varied the distance
between motif match and transcription start site to determine if this could have an impact on
the robustness of the network as defined above. While increasing the distance between
transcription factor binding site and transcription start site could lead to erroneous edges in
the network, we evaluated the specificity and sensitivity of SAMNet using transcription
factor binding sites up to one, three, five and ten kilobases upstream of the transcription start
site. We found that allowing for transcriptional binding up to five kilobases upstream of the
transcription start site provided the network that was most robust to random variation of
input data across the distances tested (Table S3, Figure S5).
Network visualization and functional interpretation
We used Cytoscape28 to visualize the networks. This tool enabled us to select for high flow
nodes or edges as depicted in Figure 3 and also to focus on different subsets of nodes that
we found to be interesting (Figure 5).
To identify terms that were over-represented in specific commodities within the network, we
used the GOstats and Category packages from Bioconductor11 to compute the hyper-
geometric probability of a given GO term or KEGG pathway (respectively) being over-
represented within a specific set of terms compared to the entire network. We used GOStats
to compute the conditional p-value for the GO enrichment to account for the graphical
hierarchy of the ontology because standard false discovery rate (FDR) p-values are not
reliable given the relationship between each of the terms in the ontology. For each
commodity k, we identified the vertex set n that have at least one edge carrying commodity
k and searched for categories with a higher expected number of proteins in n than expected
by chance (p<0.01 for Yeast, p<0.05 for Human) given the size of the entire flow network
(1706 nodes in Yeast dataset, 357 nodes in Human). While using such a small background
reduces the significance of the enrichment p-values, we believe it compensates for biases in
the interactome and the input data to only focus on those processes that are distinct for each
commodity. The most significant yeast terms are shown in Table 3 (for interest of space
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only those terms with p<0.001 are shown, full results are shown in Table S2). For the human
dataset we found KEGG terms to be more informative and thus included those in Table 4
(p<0.05) but still listed all GO terms (p<0.05) in Table S4. We used a higher p-value
threshold for the human data because the lower number of nodes led to a decrease in
statistical significance.
We also used functional enrichment to compare nodes identified by SAMNet for a specific
commodity and ResponseNet on the same data. For each value of γ we calculated GO terms
identified as enriched (p<0.05 according to fishers exact test) for both SAMNet and
ResponseNet. We then calculated the fraction of terms unique to a particular algorithm
compared to all terms identified by both algorithms in Figure 2C. To illustrate that the terms
identified were unique to specific commodities, we performed the same comparison across
terms that were not shared between two or more commodities in Figure 2D. For most
commodities, SAMNet was able to identify more unique GO terms for each commodity than
the corresponding ResponseNet network.
Scanning network for putative drug targets
To determine if the network was over-represented among various drug-targets, we
downloaded a list of drug-protein interactions from PharmGKB (http://
www.pharmGKB.org)29. We then computed, for each drug in the database, the number of
targets that were found in the EMT network and computed the probability of finding this
many drug targets by chance via Fisher's exact test. Full results are in Table S5.
Results
SAMNet identifies condition-specific genes to enable multi-dimensional data analysis
The primary enhancement of SAMNet over previous optimization algorithms is the ability
to model multiple conditions simultaneously to reveal condition-specific response pathways.
The capacity constraint (Equation 4) in the optimization criteria requires that the flow
through an edge for each commodity must only be enough such that the sum of flow over all
commodities is less than the edge capacity. Therefore, the algorithm must consider all
commodities when determining how much flow for each commodity can be sent along each
edge in the network. The goal is to leverage the availability of multiple conditions, creating
a unified network that highlights pathways that are distinct to each condition without ruling
out the possibility that two cellular conditions can indeed share interactions if the
experimental results dictate such behavior.
To determine if this enhancement had a significant impact on the result, we compared the
SAMNet network with the result of running each perturbation separately with the same
value of γ using ResponseNet22. Our results in Figure 2 show the graph statistics for the
SAMNet graph compared to the individual ResponseNet graphs using the same parameters.
When run with the same parameters, SAMNet identifies for each commodity a subset of the
ResponseNet graph run on the same data that is highly enriched in condition-specific GO
categories when compared to other conditions. Figure 2A illustrates how 40-60% of the
nodes identified by SAMNet are unique to each commodity while ~80% of the nodes in
each individual ResponseNet network are shared across all experiments. We get similar
results when we compare fraction of unique edges in the network in Figure 2B, with
SAMNet identifying more commodity-specific interactions than ResponseNet run
individually on each data set. We also compared SAMNet to the Prize Collecting Steiner
Forest (PCSF) algorithm which takes an alternate optimization approach to identify highly
likely edges in an interaction network 30. Our results, depicted in Figure S7, illustrate that
while the PCSF identifies more distinct nodes and edges than ResponseNet, more than 50%
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of each solution is shared with other commodities. These results indicate that the while
PCSF outperforms ResponseNet in identifying relevant networks, it is not as well suited as
SAMNet for finding the pathways specific to each member of a set of perturbations.
To further compare SAMNet with ResponseNet with respect to the ability to generate
functionally relevant networks we calculated the GO terms enriched for each commodity as
described in Materials and Methods. For every value of γ we computed the GO terms
enriched for each set of nodes involved in a particular chemical treatment identified by
either SAMNet or ResponseNet. The results, shown in Figure 2C, illustrate that for all but
the lowest value of γ SAMNet identifies more GO terms for each commodity than
ResponseNet. Because we are interested in GO terms that are unique for each commodity,
we eliminated each GO term that was enriched in more than one commodity to determine if
SAMNet was still able to identify more unique GO terms than ResponseNet, shown in
Figure 2D.
The full SAMNet network for yeast contains 1706 nodes and 2662 edges (Figure S6). We
summarize the final network in Figure 3, which depicts those edges that consume the highest
amount of flow. While it omits most nodes, even the summarized network in Figure 3
provides a mechanistic explanation of how divergent genetic hits can converge on common
yeast stress response pathways as well as shared pathways across various metals. For
example, the vacuolar (H-)-ATPase (V-ATPase) complex9 is targeted by silver and zinc.
While many elements of this complex are genetic hits (VPH2, VMA7, VMA8, VMA6,
VMA4, VMA2, VMA21 and VMA22 in zinc and VMA9 in silver), SAMNet identifies
other members of V-ATPase complex as relevant, such as VPH1, which was not identified
as a genetic hit, or VMA21 and VMA2, which were genetics hits in the zinc treatment but
not in the silver treatment. Furthermore, the high degree of similarity between the silver and
zinc treatments, while indicated in the original clustering of the mRNA expression data
(Figure S1) was not evident in the genetic hit data and illustrates how SAMNet can infer
pathways even with missing data. Because flow is forced through both genetic hits and
differentially expressed genes equally, the algorithm can compensate for missing data in one
type of assay.
Across more than half of the conditions, SAMNet implicates RAV1 and SKP1, members of
the RAVE complex which is also a regulator of the V-ATPase complex31. The large amount
of flow passing through these proteins corresponds to their centrality in cellular processes9,
confirmed by the essentiality of SKP1. Proteins with flow shared across most of the
commodities encompass general stress-related functions such as HSF1, TOR1, GCN4 and
GLN3 which are involved in cellular stress as well as MSN2, an environment stress
regulator32. Lastly we also see metal-specific proteins involved in the shared response, such
as YAP family members CIN5 and YAP113. It is important to note that many proteins that
are important in the processing of heavy metals, such as VPH1 and YAP1, were not detected
in the original genetic or mRNA experiments for any commodities despite their well-known
role in metal processing. Overall, however, SAMNet identifies putative nodes involved in
each commodity beyond those originally detected and thus facilitates discovery of
underlying biological processes involved.
SAMNet can identify biological processes affected by different perturbations
One of the primary challenges of identifying signaling pathways specific to various cellular
perturbations is the fact that many responses share similar pathways. By forcing all
perturbations to “share” flow through capacitated edges, SAMNet is forced to distribute
flow across multiple relevant pathways. As mentioned above, 40-60% of the nodes in each
commodity are unique to that commodity, allowing sufficient sample size to search for
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enriched biological processes in the Gene Ontology (GO) graph. Table 1 shows the GO
Biological Process terms uniquely enriched in sets of commodity-specific nodes at p<0.001.
Our approach recovers many of the effects of each metal that were not identifiable with the
combined single commodity approach. For example, the proteins ascribed to the mercury
commodity are over-represented among cell wall biogenesis-related genes, which has been
documented in Hg+ resistant strains of Yeast33. Cadmium has been identified as playing a
role in chromatin modification in human cell lines34. Zinc-specific proteins are enriched in
vesicle transport which has been observed at the phenotypic level35. Lastly, the
overwhelming number of RNA and ribosomal-associated terms in the copper commodity
also has experimental support, as copper has been implicated in hepatic RNA-processing
defects in mouse disease models36.
SAMNet identifies key mediators of epithelial-mesenchymal transition (EMT)
Having shown that SAMNet can identify condition-specific undetected proteins, we moved
to a less characterized system in a more complex organism to determine if the algorithm can
identify relevant pathways. Using the same underlying network formulation, we identified
protein-protein and protein-DNA interactions that best explain changes in phospho-protein
levels upstream of mRNA expression levels across four models of EMT. These four models
included H358 cells induced with over-expression of Zeb1, H358 cells induced with over-
expression of Snail, H358 cells induced by stimulation with TGFβ and Calu6/H1703 cells to
represent an epigenetically fixed mesenchymal model (see Methods). For each model,
phopho-proteomic and mRNA expression fold changes were collected and run together as a
separate commodity in the SAMNet algorithm. The final network, comprised of 357 nodes
and 411 edges, is depicted in Figure 4a.
The nodes in the network representing a large amount of flow (indicated by the size of the
node) are generally well-known mediators of cancer. For example, high-flow nodes GRB2,
SRC and EGFR have been identified as regulators of cancer progression37. Key
transcriptional regulators ESR1 and TP53 were identified by the algorithm as regulating
differentially expressed genes across multiple conditions38. Figure 4B depicts the network
surrounding β-catenin (CTNNB1) and TCF7L2, also known as TCF4.
This interaction is a hallmark of EMT in which E-Cadherin (CDH1 in Figure 4B) becomes
phosphorylated and releases β-catenin from the membrane, causing it translocate to the
nucleus where it activates TCF7L2/TCF4 and LEF1 transcription factors 39. While these
proteins were found to be slightly active in the fixed mesenchymal cell line (grey), they
exhibit strong mRNA regulatory effects in the TGF β and Snail - induced cell lines
suggesting that this activity may be related to the transition from the epithelium to the
mesenchyme, since it is not present in the fixed cell line. TCF7L2 and CTNN1B were absent
from the original experiments due to lack of detectable fold change (as their interaction is
activated by translocation). Nevertheless, SAMNet was able to identify these proteins as key
mediators of EMT. Based on these results, we would suggest that perturbing the E-Cadherin
pathway might disrupt TGF β and Snail – induction of EMT to a greater degree than Zeb1-
induction.
SAMNet can specifically identify signaling changes in various EMT models
The large degree of dissimilarity between transition metal treatments in the yeast dataset
made it fairly straightforward to identify condition-specific proteins involved in each
perturbation. Therefore it was surprising that, given the high degree of similarity between
the various experiments in the EMT data, we were able to identify unique KEGG pathways
(p<0.05) among nodes ascribed to each condition, described in Table 4.
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Many of the over-represented KEGG terms are in line with what is expected of the various
cellular conditions. For example, the fixed condition is highly enriched in genes involved in
epithelial cell signaling and the TGFβ model includes EMC-receptor interaction related
genes. Also, various cancer pathways (including non-small cell lung cancer) are identified
across all conditions. However, there are less-expected patterns as well. The JAK-STAT
pathway was unique to the fixed mesenchymal model, suggesting that this pathway and its
anti-apoptotic effects are not present in cancer cells until after the transition to the
mesenchyme. The Snail condition was enriched in adherens junction-related proteins while
TGFβ was enriched in Gap junction related proteins, suggesting a possible division of tasks
across various EMT signaling proteins. Interestingly, the spliceosome pathway appeared
highly enriched among Zeb1-related proteins. A recent study of EMT in a human mammary
epithelial cell line (HMLE) identified alternative splicing as a key mechanism of EMT,
leading to the many alternatively spliced isoforms that can make cells more invasive40.
When we searched for enriched KEGG terms in the ResponseNet networks in a similar
fashion, we only found enriched terms for the fixed commodity (Table S6) suggesting that
SAMNet is a necessary improvement to study these pathways.
To further investigate condition-specific pathways, we manually selected sub-networks of
interest from the larger EMT network to illustrate how SAMNet can be used to generate
further hypotheses from multiple high throughput experiments. Figure 5A highlights the
transcriptional role of ESR1 predominantly in the Snail induced model. Snail has been found
to repress ESR1 during EMT41. This same work identified significant cross-talk between the
TGFβ pathway and the Snail-ESR1 pathway as well, suggesting that the identification of this
transcription factor is biologically relevant. Based on the SAMNet results, we suggest that
estrogen receptor agonists and antagonists are more likely to alter Snail-induced EMT
compared to Zeb1 and TGFβ induction.
Figure 5B shows interactions with NFKB2, a subunit of the NFκβ complex and a node that
is uniquely selected by the induced models. Interestingly, while much is known about the
NFκβ complex in its entirety, very little is known about its individual components42 and this
network provides a putative mechanism by which early EMT can regulate cancer
progression. We hypothesize that specific inhibition of NFKB2 could inhibit the transition
of these cells.
Lastly, we focused on the elements of the spliceosome that were selected by the network,
labeled in grey in Figure 5C along with their immediate neighbors. Interestingly, five out of
nine of the spliceosome-related proteins were phosphorylated in either the Zeb1 or Snail
induced models. This suggests that phosphorylation of members of the spliceosome can alter
the splicing behavior during induction of EMT. In each of the cases cited above, the nodes
found by SAMNet could be detected by ResponseNet network under some parameter
settings. However, many of the condition-specific events were muted as the nodes were
shared by other conditions, making identification of KEGG pathways impossible (Table S6).
By identifying compact, condition-specific networks, SAMNet makes it easier to generate
high-priority hypotheses for experiments.
SAMNet network can be used to identify novel drugs to treat lung cancer
To explore other applications of SAMNet, we scanned the proteins identified in EMT across
all genes in PharmGKB, an online repository of drug-gene interactions to see if the network
was enriched in targets of known cancer drugs. We performed Fisher's exact test to search
for drugs that had a significantly large number of interactions with genes in the full EMT
network. We identified 47 compounds with a significant (p<0.001) number of interacting
genes in the network. Table S5 describes the drugs from PharmGKB, the overlap of their
predicted targets with genes in the network, and the relative contribution of each commodity
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to the set of genes. Interestingly, the most significant cancer-related compound was imatinib,
also known as Gleevec, a BCR-ABL inhibitor that was designed to treat a specific mutation
in chronic myelogenous leukeumia (CML) that has predicted effects on genes across all four
EMT models. While this drug has not been approved to treat non-small cell lung cancers,
previous work has found that it potentiates cisplatin to enhance cell death of NSCLC cell
line A54943. Another study identified that the same compound can inhibit TGFβ-induced
cellular proliferation suggesting that Gleevec's synergy with cisplatin is directly related to
EMT induction44. These two studies, coupled with the over-representation of Gleevec-
affected genes in our network, suggest that Gleevec could have an effect on targeting the
growth of NSCLC cells through EMT-initiated pathways. The next relevant drugs identified
were gemcitabine and gefitinib, both approved drugs for many carcinomas including non
small-cell lung cancer.
Discussion
Before the development of high throughput technologies, biological hypotheses were tested
one at a time between a control and a test condition (e.g. a healthy and diseased tissue). To
analyze these results, scientists only needed to plot the values in two dimensions to
determine if there was a difference between the samples. However, as the number of
conditions has increased along with the number of assays performed, analysis of these high
throughput datasets has failed to keep pace. Examples of large, multidimensional datasets
include the cancer genome atlas (TCGA)45, which has a large repository of cancer tumor
data across 20 cancers including genetic, mRNA expression, miRNA expression and other
forms of data. Within breast cancer alone, there is also a large amount of cell line data46
measuring the response of 24 different drugs in over 400 cancer cell lines. These datasets
provide the ability to identify specific differences between various classes of patients or cell
lines with greater statistical power than a basic two-condition test. However, as these large
experiments become more common, the need for tools that capitalize on the increased
availability of data has only increased.
Here we introduce SAMNet, an algorithm that is able to identify unique pathways active
across multiple experiments while still taking into account results of multiple assays. By
forcing each experimental condition to share edges in a capacitated and weighted network,
our approach can distinguish protein interactions that are distinct to specific conditions from
those that are shared. Given the structure of protein-protein interaction networks weighted
by evidence, most constrained optimization approaches9,11 will always select the highest
confidence edges that explain the data, even if these same edges can also explain other,
unrelated, data. The selected edges can also be biased toward the experimental platform at
hand, and not the differences between the cellular conditions. While these algorithms use
permutation tests to identify proteins/pathways that are specifically over-represented in the
final network, SAMNet eliminates the need for this step by considering all conditions at
once and selecting the best edges for each. While multi-commodity flow has been used
previously in the context of the protein interaction network15,16, the model was much more
constrained with the end goal of identifying relevant RNA interference hits that explain
changes in expression of a single gene. SAMNet is data-agnostic and is easily applied to
various experimental setups and data types.
Our ability to demonstrate SAMNet on both a yeast system with highly dissimilar treatments
as well as a human system with highly related experiments shows the algorithm is a useful
and broadly applicable tool to help scientists interpret high throughput data. We illustrate
how the algorithm can identify biological processes uniquely affected in one condition
versus another. By generating specific hypotheses SAMNet can aid experimentalists in
designing specific follow-up experiments, such as targeting the subnetworks in Figure 5, to
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affect cells in one state (e.g. Snail-induced epithelial cells) while not affecting others. As
more large scale and collaborate efforts generate data across various conditions and patients
we believe that SAMNet will provide a useful tool to integrate these experiments, enhance
functional enrichment and provide specific subnetworks that can best explain the observed
results.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Insight statement
The increasing use of high throughput technologies in biology has led to an
overwhelming amount of data. As the cost of genome-wide assays has dropped,
experiments across various cellular conditions at once are no longer uncommon. Here we
introduce SAMNet, an optimization algorithm that uses the underlying protein-protein
interaction network to integrate results from multiple types of assays across various
conditions, highlighting genes and pathways that might have been missed by the original
experiments but are relevant to the underlying cellular process. We illustrate how
SAMNet can be used to integrate genetic mutant data and mRNA expression data across
seven conditions in budding yeast as well as phosphorylation data and mRNA expression
data in a model of Epithelial-Mesenchymal transition (EMT) in lung cancer.
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Figure 1.
The integration of four distinct data types into a single weighted graph with the auxiliary
nodes S and T. Four different conditions are represented, with the genetic hits/
phosphorylated proteins (squares) and differentially expressed mRNA (diamonds) derived
from distinct experiments. Internal nodes (circles) are derived from the interactome. Black
edges represent data from published interactions, colored edges represent chemical-specific
data. Dashed edges represent protein –DNA interactions while solid edges represent protein-
protein interactions.
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Figure 2.
Comparison of SAMNet and ResponseNet. Fraction of unique (A) nodes and (B) edges in
each commodity of SAMNet for the various values of γ compared to the original
ResponseNet networks on each independent condition. Fraction of (C) all and (D) unique (to
a specific condition) GO terms identified by SAMNet (per commodity) and ResponseNet
(on corresponding condition).
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Figure 3.
Subset of Yeast transition metal interactome with edge flow values greater than 0.005.
Larger node size indicates more flow, while color indicates conditions in which that node/
edge is determined to be active. The direction of edges represents flow from genetic hits
(rectangles) to mRNA nodes and the color of the edges represents the commodity that was
selected to use that edge. Pie charts correspond to fraction of flow for each commodity
passing through the node. Graph generated and filtered by Cytoscape28
Gosline et al. Page 19
Integr Biol (Camb). Author manuscript; available in PMC 2013 November 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 4.
(A) Full EMT network annotated in a similar fashion to Figure 3. Phosphorylated proteins
are represented by rectangles while non-phosphorylated proteins have grey borders. Pie
charts represent flow distribution through nodes, while edge color represents the condition in
which that edge was selected. (B) CTNNB1 and TCF7L2 and their interacting nodes.
Gosline et al. Page 20
Integr Biol (Camb). Author manuscript; available in PMC 2013 November 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 5.
(A) Role of ESR1 in Snail and TGFβ pathways (B) NFKB2 activity in induced models only
(C) Spliceosome-related proteins (according to KEGG) and their interacting partners
identified by SAMNet in two induced models. Differentially phosphorylated proteins are
represented by rectangles while those inferred by SAMNet are encircled in the black square.
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Table 1
Sizes of Yeast metal datasets used for SAMNet. Genetic hits identified in the original screen that were not in
the STRING interactome were removed from consideration.
Metal Treatment Genetic hits Differentially expressed mRNA Overlap
Arsenic 38 566 1
Cadmium 49 898 6
Chromium 59 861 6
Copper 39 815 7
Mercury 3 877 0
Silver 2 814 0
Zinc 38 839 1
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Table 2
Sizes of Human EMT datasets used for SAMNet.
EMT State Phospho-proteins Differentially expressed mRNA Overlap
Fixed 132 131 13
Snail 14 1019 5
TGFβ 58 1020 28
Zeb1 14 1019 6
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Table 3
GO Terms enriched (p<0.001) for proteins ascribed to be related to a single metal treatment by SAMNet
commodity Term GOBPID Pvalue
arsenic negative regulation of transcription from RNA polymerase II promoter GO:0000122 1.35E-004
arsenic tubulin complex assembly GO:0007021 2.52E-004
arsenic osmosensory signaling pathway GO:0007231 3.17E-004
arsenic cellular response to abiotic stimulus GO:0071214 3.17E-004
arsenic regulation of catalytic activity GO:0050790 4.16E-004
arsenic filamentous growth of a population of unicellular organisms GO:0044182 4.33E-004
arsenic pseudohyphal growth GO:0007124 5.07E-004
arsenic regulation of cell communication GO:0010646 5.85E-004
arsenic regulation of signaling process GO:0023051 5.85E-004
arsenic negative regulation of signal transduction GO:0009968 9.40E-004
cadmium covalent chromatin modification GO:0016569 1.76E-004
cadmium signaling GO:0023052 4.45E-004
cadmium response to DNA damage stimulus GO:0006974 6.33E-004
cadmium response to stress GO:0006950 8.19E-004
cadmium TOR signaling pathway GO:0031929 9.83E-004
chromium negative regulation of transcription GO:0016481 8.13E-006
chromium negative regulation of RNA metabolic process GO:0051253 1.08E-005
chromium negative regulation of biosynthetic process GO:0009890 1.77E-005
chromium negative regulation of nitrogen compound metabolic process GO:0051172 2.75E-005
chromium negative regulation of biological process GO:0048519 1.89E-004
chromium negative regulation of cellular metabolic process GO:0031324 1.97E-004
chromium regulation of cell division GO:0051302 4.35E-004
chromium chromatin silencing GO:0006342 5.87E-004
chromium regulation of gene expression, epigenetic GO:0040029 5.87E-004
copper endocytosis GO:0006897 1.57E-005
copper rRNA processing GO:0006364 3.29E-005
copper actin polymerization or depolymerization GO:0008154 4.01E-004
copper proteasome assembly GO:0043248 6.62E-004
copper ncRNA metabolic process GO:0034660 7.07E-004
mercury cell wall organization or biogenesis GO:0071554 2.12E-005
mercury cellular macromolecule biosynthetic process GO:0034645 2.28E-005
mercury signal transmission GO:0023060 6.99E-005
mercury UFP-specific transcription factor mRNA processing during unfolded protein response GO:0030969 2.47E-004
mercury reproductive developmental process GO:0003006 2.63E-004
mercury barrier septum formation GO:0000917 5.99E-004
mercury regulation of signal transduction GO:0009966 7.53E-004
mercury regulation of cellular component size GO:0032535 8.90E-004
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commodity Term GOBPID Pvalue
mercury cell communication GO:0007154 9.36E-004
silver meiotic DNA double-strand break formation GO:0042138 8.45E-006
silver mitochondrial signaling pathway GO:0031930 4.05E-005
silver SCF-dependent proteasomal ubiquitin-dependent protein catabolic process GO:0031146 4.68E-005
silver double-strand break repair via homologous recombination GO:0000724 8.96E-005
silver G1/S transition of mitotic cell cycle GO:0000082 6.81E-004
silver DNA catabolic process GO:0006308 8.59E-004
zinc Golgi vesicle transport GO:0048193 9.74E-005
zinc Golgi to vacuole transport GO:0006896 3.97E-004
zinc cell cycle phase GO:0022403 8.49E-004
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Table 4
KEGG pathways enriched (p<0.05) for proteins ascribed to a single EMT state
commodity Term KEGGID Pvalue
fixed Chronic myeloid leukemia 05220 0.000478681
fixed Epithelial cell signaling in Helicobacter pylori infection 05120 0.000680791
fixed Adipocytokine signaling pathway 04920 0.004669895
fixed Pancreatic cancer 05212 0.00722651
fixed Acute myeloid leukemia 05221 0.010175165
fixed Jak-STAT signaling pathway 04630 0.013123511
fixed Huntington's disease 05016 0.013942901
fixed Peroxisome 04146 0.031660636
fixed T cell receptor signaling pathway 04660 0.032080957
fixed Small cell lung cancer 05222 0.032080957
fixed Cell adhesion molecules (CAMs) 04514 0.036944687
fixed Melanoma 05218 0.048088525
tgfb GnRH signaling pathway 04912 0.000957486
tgfb ECM-receptor interaction 04512 0.006782428
tgfb MAPK signaling pathway 04010 0.015789683
tgfb Pathogenic Escherichia coli infection 05130 0.018867568
tgfb Axon guidance 04360 0.024357116
tgfb Gap junction 04540 0.032635449
tgfb NOD-like receptor signaling pathway 04621 0.032635449
tgfb Neurotrophin signaling pathway 04722 0.035733824
zeb1 Spliceosome 03040 2.21E-05
zeb1 Histidine metabolism 00340 0.033517425
snail Endometrial cancer 05213 0.002423778
snail Adherens junction 04520 0.018937741
snail Non-small cell lung cancer 05223 0.041822122
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